Sarasota, FL (PRWEB) April 07, 2015 -- AltMed, the Florida company that brings pharmaceutical industry precision to the development and production of medical cannabis, will be presenting on the Cannabis Investor Webcast on Thursday, April 9, 2015 at 11:00 AM ET.
"The Cannabis Investor Webcast is an online interactive platform that will allow us to share AltMed's innovative approach, recent developments and exciting opportunities with the Cannabis Investor Webcast online community," said David Wright, CEO of AltMed.
The Cannabis Investor Webcast includes presentations from privately-held and publicly-traded industry companies and industry professionals. AltMed’s presentation will be 30-minutes long and followed by 15-minutes of Q&A. The Cannabis Investor Webcast is a great opportunity for the audience to research industry companies without taking time-off from work, paying registration fees and incurring travel-related expenses.
"We're excited that AltMed has decided to present to our online audience of industry investors, research analysts, executives, media, and consumers," said Derwin A. Wallace, Senior VP of Investor Webcast. "The online interactive webcast will assist AltMed in increasing its awareness and exposure."
Cannabis investors, research analysts, executives, media, and consumers can attend the free online webcast by following this link http://www.cannawebcast.com and visit the Registration Page. To view the recording of the webcast please visit YouTube.com and search for ‘Cannabis Investor Webcast’ two weeks after the live presentation.
About AltMed
AltMed LLC is a fully integrated company that will bring pharmaceutical industry precision to the development, production and dispensing of medical cannabis. Established in early 2014 by a consortium of Sarasota residents, AltMed’s Executive Chairman and its CEO are both former senior pharmaceutical executives. Their previous company, MedImmune (acquired by Astra Zeneca in 2007), produces a drug for the prevention of respiratory infections in infants. AltMed is participating in a competitive licensure process to become one of five Florida licensees to be selected to grow and dispense medical cannabis under the Compassionate Medical Cannabis Act of 2014.
Colin Trethewey, PRmediaNow, http://prmedianow.com/, +1 (813) 480-1354, [email protected]
Share this article